Francisco Esteban

1.9k total citations
69 papers, 1.5k citations indexed

About

Francisco Esteban is a scholar working on Oncology, Surgery and Otorhinolaryngology. According to data from OpenAlex, Francisco Esteban has authored 69 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 16 papers in Surgery and 16 papers in Otorhinolaryngology. Recurrent topics in Francisco Esteban's work include Head and Neck Cancer Studies (11 papers), Immunotherapy and Immune Responses (9 papers) and T-cell and B-cell Immunology (8 papers). Francisco Esteban is often cited by papers focused on Head and Neck Cancer Studies (11 papers), Immunotherapy and Immune Responses (9 papers) and T-cell and B-cell Immunology (8 papers). Francisco Esteban collaborates with scholars based in Spain, Brazil and Italy. Francisco Esteban's co-authors include Miguel Ángel González‐Moles, Francisco Ruiz‐Cabello, Federico Garrido, Isabel Ruiz‐Ávila, Ángel Concha, Maximino Redondo, Miguel Muñoz, José Antonio Gil Montoya, Miguel Delgado‐Rodríguez and Millán Perez‐Ayala and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer and Journal of neurosurgery.

In The Last Decade

Francisco Esteban

67 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francisco Esteban Spain 23 498 431 342 284 277 69 1.5k
Kiyoshi Misawa Japan 25 492 1.0× 61 0.1× 915 2.7× 231 0.8× 263 0.9× 100 1.7k
Anastasia Filia Greece 16 269 0.5× 326 0.8× 380 1.1× 164 0.6× 243 0.9× 31 1.1k
Maria Nyström Sweden 17 556 1.1× 502 1.2× 348 1.0× 44 0.2× 33 0.1× 26 1.3k
Cynthia Webb Israel 21 490 1.0× 494 1.1× 645 1.9× 117 0.4× 15 0.1× 34 1.6k
Anna Maria Chiaravalli Italy 30 990 2.0× 352 0.8× 447 1.3× 963 3.4× 26 0.1× 82 2.5k
Gillian L. Hall United Kingdom 18 282 0.6× 120 0.3× 304 0.9× 245 0.9× 378 1.4× 32 1.0k
Chris W. Doornebal Netherlands 8 817 1.6× 1.0k 2.3× 326 1.0× 139 0.5× 8 0.0× 11 1.7k
Martti Maimets Denmark 11 430 0.9× 79 0.2× 429 1.3× 169 0.6× 47 0.2× 19 1.2k
Corinne M. Goldsmith United States 25 145 0.3× 45 0.1× 642 1.9× 114 0.4× 121 0.4× 43 1.4k
Sophie Laberge France 23 189 0.4× 434 1.0× 149 0.4× 264 0.9× 12 0.0× 46 2.0k

Countries citing papers authored by Francisco Esteban

Since Specialization
Citations

This map shows the geographic impact of Francisco Esteban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francisco Esteban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francisco Esteban more than expected).

Fields of papers citing papers by Francisco Esteban

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francisco Esteban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francisco Esteban. The network helps show where Francisco Esteban may publish in the future.

Co-authorship network of co-authors of Francisco Esteban

This figure shows the co-authorship network connecting the top 25 collaborators of Francisco Esteban. A scholar is included among the top collaborators of Francisco Esteban based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francisco Esteban. Francisco Esteban is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burgos, Manuel A., et al.. (2024). Reducing variability in nasal surgery outcomes through computational fluid dynamics and advanced 3D virtual surgery techniques. Heliyon. 10(5). e26855–e26855. 3 indexed citations
2.
González‐Moles, Miguel Ángel, Pablo Ramos‐García, & Francisco Esteban. (2021). Significance of the Overexpression of Substance P and Its Receptor NK-1R in Head and Neck Carcinogenesis: A Systematic Review and Meta-Analysis. Cancers. 13(6). 1349–1349. 12 indexed citations
3.
Esteban, Francisco, Pablo Ramos‐García, Miguel Muñoz, & Miguel Ángel González‐Moles. (2021). Substance P and Neurokinin 1 Receptor in Chronic Inflammation and Cancer of the Head and Neck: A Review of the Literature. International Journal of Environmental Research and Public Health. 19(1). 375–375. 16 indexed citations
4.
Esteban, Francisco, et al.. (2020). The substance P and neurokinin-1 receptor system in human thyroid cancer: an immunohistochemical study. European Journal of Histochemistry. 64(2). 17 indexed citations
5.
Kaen, Ariel, et al.. (2018). Refining the anatomic boundaries of the endoscopic endonasal transpterygoid approach: the “VELPPHA area” concept. Journal of neurosurgery. 131(3). 911–919. 15 indexed citations
7.
González‐Moles, Miguel Ángel, Francisco Esteban, Isabel Ruiz‐Ávila, et al.. (2008). A role for the substance P/NK‐1 receptor complex in cell proliferation and apoptosis in oral lichen planus. Oral Diseases. 15(2). 162–169. 24 indexed citations
8.
Muñoz, Miguel, et al.. (2007). NK-1 receptor antagonists induce apoptosis and counteract substance P-related mitogenesis in human laryngeal cancer cell line HEp-2. Investigational New Drugs. 26(2). 111–118. 69 indexed citations
9.
Esteban, Francisco, José Luís Royo, Miguel Ángel González‐Moles, et al.. (2007). CAPN10 alleles modify laryngeal cancer risk in the Spanish population. European Journal of Surgical Oncology. 34(1). 94–99. 7 indexed citations
10.
Esteban, Francisco, et al.. (2006). Malignant melanomas of the nasolacrimal duct. The Journal of Laryngology & Otology. 121(3). 285–288. 5 indexed citations
11.
Esteban, Francisco, et al.. (2005). Adhesion molecule CD44 as a prognostic factor in laryngeal cancer.. PubMed. 25(2A). 1115–21. 17 indexed citations
12.
González‐Moles, Miguel Ángel, et al.. (2004). Adhesion molecule CD44 as a prognostic factor in tongue cancer.. PubMed. 23(6D). 5197–202. 22 indexed citations
13.
Esteban, Francisco, et al.. (2003). Tratamiento de los granulomas de laringe con medicación anti-reflujo extraesofágico. Acta Otorrinolaringológica Española. 54(7). 501–505. 2 indexed citations
14.
Esteban, Francisco, et al.. (2001). Morbilidad “habitual” de la amigdalectomía pediátrica: Estudio de 126 casos. Acta Otorrinolaringológica Española. 52(5). 390–395. 6 indexed citations
15.
Redondo, Maximino, et al.. (2001). Carcinoma basaloide escamoso de laringe e hipofaringe: Presentación de una serie de 6 casos. Acta Otorrinolaringológica Española. 52(3). 229–236. 14 indexed citations
16.
Esteban, Francisco, et al.. (1999). [Hypothyroidism in patients treated for laryngeal cancer: preliminary results].. PubMed. 50(3). 205–10. 3 indexed citations
17.
Esteban, Francisco, Maximino Redondo, Miguel Delgado‐Rodríguez, Federico Garrido, & Francisco Ruiz‐Cabello. (1996). MHC class I antigens and tumour-infiltrating leucocytes in laryngeal cancer: long-term follow-up. British Journal of Cancer. 74(11). 1801–1804. 24 indexed citations
18.
Esteban, Francisco, et al.. (1990). Relationship of 4F2 antigen with local growth and metastatic potential of squamous cell carcinoma of the larynx. Cancer. 66(7). 1493–1498. 28 indexed citations
19.
20.
Esteban, Francisco, Ángel Concha, Millán Perez‐Ayala, et al.. (1989). Histocompatibility antigens in primary and metastatic squamous cell carcinoma of the larynx. International Journal of Cancer. 43(3). 436–442. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026